Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$3.2 million.

  • HCW Biologics' Free Cash Flow fell 561.99% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 million, marking a year-over-year increase of 3797.96%. This contributed to the annual value of -$16.2 million for FY2024, which is 4345.49% up from last year.
  • HCW Biologics' Free Cash Flow amounted to -$3.2 million in Q3 2025, which was down 561.99% from -$3.3 million recorded in Q2 2025.
  • HCW Biologics' Free Cash Flow's 5-year high stood at -$990440.0 during Q2 2021, with a 5-year trough of -$12.5 million in Q3 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$3.5 million (2025), whereas its average is -$4.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 30508.33% in 2023, then soared by 6143.9% in 2024.
  • Over the past 5 years, HCW Biologics' Free Cash Flow (Quarter) stood at -$3.4 million in 2021, then dropped by 13.59% to -$3.9 million in 2022, then crashed by 97.26% to -$7.6 million in 2023, then soared by 61.44% to -$2.9 million in 2024, then decreased by 10.4% to -$3.2 million in 2025.
  • Its Free Cash Flow stands at -$3.2 million for Q3 2025, versus -$3.3 million for Q2 2025 and -$3.5 million for Q1 2025.